This 8.7% Dividend Clobbers Stocks (and It’s Selling for 13.7% Off)
It’s a recent addition to the CEF Insider portfolio.
Read Moreby Michael Foster, Contrarian Outlook | Jun 18, 2026
It’s a recent addition to the CEF Insider portfolio.
Read Moreby Sean Williams, The Motley Fool | Jun 18, 2026
The rewriting of several major index inclusion criteria has set retail investors up to be fleeced.
Read Moreby David Bartosiak, Zacks | Jun 18, 2026
It offers a great Zacks Rank, years long tailwinds, and a promise of more profits to come
Read Moreby Eric Volkman, The Motley Fool | Jun 17, 2026
Both names have above-average dividend yields and have a very strong presence in their respective markets.
Read Moreby Brett Owens, Contrarian Outlook | Jun 17, 2026
It’s trading more than 25% off the all-time high it hit in late 2024… an absurd price for a company generating $14 billion in yearly free cash flow.
Read Moreby Brett Eversole, DailyWealth.com | Jun 17, 2026
Right now, stocks are in a strong uptrend… and you never want to fight a bull market.
Read Moreby TheFly.com | Jun 17, 2026
Here are today’s upgrades and downgrades: Macerich, Credicorp, Cognizant, Anglo American, MFA Financial and more.
Read Moreby Andrew Rocco, Zacks | Jun 16, 2026
And its stock is retreating to the rising 50-day moving average, offering a high probability reward-to-risk zone.
Read Moreby Michael Foster, Contrarian Outlook | Jun 16, 2026
Not only does it have high, and growing dividends, but it’s currently trading at a 12.5% discount to NAV.
Read Moreby Chris Igou, DailyWealth.com | Jun 16, 2026
With gold breaking below its 200-day moving average, the market is showing us that we need to take the sell-off seriously.
Read Moreby TheFly.com | Jun 16, 2026
Here are today’s upgrades and downgrades: Roku, Exxon Mobil, Palantir, Tanger, Rocket Companies, Centerspace and more.
Read Moreby Jason Fieber, Dividends And Income | Jun 15, 2026
With a market-like yield, double-digit dividend growth, a low payout ratio, nearly 20 consecutive years of dividend increases, and the potential that shares are 10% undervalued, this looks like a rare opportunity to snap up this high-quality compounder.
Read More